Molecular identification of HLA‐B75 serotype markers by qPCR: A more inclusive pharmacogenetic approach before carbamazepine prescription
Clinical and Translational Science · 2024
DOI: 10.1111/cts.13867 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, 2024. Verfasst von Kanoot Jaruthamsophon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Human Genetic Unit, Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. Hauptthemen laut MEDLINE: Carbamazepine, HLA-B15 Antigen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Faculty of Medicine, Prince of Songkla University, Health System Research Institute under the Genomics Thailand Strategic Fund, the International Research Network - the Thailand Research Fund.
Abstract (Originalsprache)
Genetic screening for HLA‐B*15:02 before prescribing carbamazepine is standard practice to prevent severe cutaneous adverse reactions in Asian populations. These reactions are associated not only with this allele but also with closely related HLA‐B75 serotype markers— HLA‐B*15:11 and HLA‐B*15:21— which are prevalent in several Asian countries. However, a reliable method for identifying HLA‐B75 serotype markers is still not available. We developed an in‐house quantitative PCR (qPCR) for HLA‐B75 screening and validated it using 303 anonymized DNA samples. Due to inadequate quality control, the qPCR results for 11 samples were excluded. We analyzed the sensitivity and specificity of the test using 93 HLA‐typed samples. The concordance between the qPCR method and an established screening method was assessed using 199 HLA‐screened samples tested for HLA‐B*15:02 at Songklanagarind Hospital, Songkhla, Thailand. All discordant results were confirmed by Sanger sequencing. The qPCR method demonstrated a sensitivity of 100% (95% confidence interval = 83.16%–100.00%) and a specificity of 100% (95% confidence interval = 95.07%–100.00%). Concordance analysis revealed a 96.5% agreement between methods (192/199; 44 positive and 148 negative results). All discordant results were due to HLA‐B75 markers not being HLA‐B*15:02 (two samples with HLA‐B*15:11 and five samples with HLA‐B*15:21 ). In conclusion, this qPCR method could be useful for identifying HLA‐B75 carriers at risk of carbamazepine‐induced reactions in Asian populations where carriers of HLA‐B*15:02 , HLA‐B*15:11 , or HLA‐B*15:21 are common.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Human Genetic Unit, Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
- Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
- Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand.
- Pharmacogenomics Clinic, Bumrungrad Genomic Medicine Institute, Bumrungrad International Hospital, Bangkok, Thailand.
- Faculty of Pharmaceutical Sciences, Burapha University, Saensuk, Mueang, Chonburi, Thailand.
- Department of Pharmacology and Therapeutics, MRC Centre for Drug Safety Science, Institute of Systems, Molecular, and Integrative Biology, University of Liverpool, Liverpool, UK.
ORCID-Profile: Kanoot Jaruthamsophon, Pornsiri Sangmanee, Oradawan Plong-On, Chariyawan Charalsawadi, Chonlaphat Sukasem, Areerat Hnoonual
Förderung
- the Faculty of Medicine, Prince of Songkla University
- Health System Research Institute under the Genomics Thailand Strategic Fund
- the International Research Network - the Thailand Research Fund
Zitieren
APA
Jaruthamsophon, K., Sangmanee, P., Plong-On, O., Charalsawadi, C., Sukasem, C., & Hnoonual, A. (2024). Molecular identification of HLA‐B75 serotype markers by qPCR: A more inclusive pharmacogenetic approach before carbamazepine prescription. Clinical and Translational Science. https://doi.org/10.1111/cts.13867
Vancouver
Jaruthamsophon K, Sangmanee P, Plong-On O, Charalsawadi C, Sukasem C, Hnoonual A. Molecular identification of HLA‐B75 serotype markers by qPCR: A more inclusive pharmacogenetic approach before carbamazepine prescription. Clinical and Translational Science. 2024. doi:10.1111/cts.13867
BibTeX
@article{Jaruthamsophon2024,
author = {Jaruthamsophon, Kanoot and Sangmanee, Pornsiri and Plong-On, Oradawan and Charalsawadi, Chariyawan and Sukasem, Chonlaphat and Hnoonual, Areerat},
title = {Molecular identification of HLA‐B75 serotype markers by qPCR: A more inclusive pharmacogenetic approach before carbamazepine prescription},
journal = {Clinical and Translational Science},
year = {2024},
doi = {10.1111/cts.13867}
}
EUVIMED